Stay updated with breaking news from Amlx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) shares were down 2.7% during mid-day trading on Friday . The company traded as low as $25.10 and last traded at $25.59. Approximately 347,433 shares traded hands during mid-day trading, a decline of 62% from the average daily volume of 904,115 shares. The stock had previously closed at […] ....
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) CFO James M. Frates sold 32,500 shares of the business’s stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $26.94, for a total value of $875,550.00. Following the completion of the transaction, the chief financial officer now owns 55,676 shares […] ....
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) insider Patrick D. Yeramian sold 11,965 shares of the business’s stock in a transaction that occurred on Monday, May 15th. The stock was sold at an average price of $29.03, for a total value of $347,343.95. Following the transaction, the insider now directly owns 208,417 shares in the […] ....
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) saw a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 6,870,000 shares, an increase of 12.6% from the April 15th total of 6,100,000 shares. Currently, 16.0% of the shares of the company are short sold. Based on […] ....
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) shares traded down 6% on Tuesday after Mizuho lowered their price target on the stock from $52.00 to $50.00. The stock traded as low as $26.42 and last traded at $26.45. 626,594 shares traded hands during mid-day trading, a decline of 31% from the average session volume of […] ....